Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...
Frontiers13 小时
Recent Advances in Radiolabeling of Biologics for Molecular Imaging of Various Brain Diseases
Radiolabeled biologics whether amino acids, cells, antibodies, proteins, viruses or synthetic ligands have potential for functional imaging and therapy. To ...
Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2024 ...
Q4 2024 total revenues of $53.2 million, +17% compared to Q4 2023 Q4 2024 Fanapt® net product sales of $26.6 million, +18% compared to Q4 2023 Full year 2024 total ...